Kano Therapeutics

Kano Therapeutics is a biotechnology company focused on developing safe and effective genetic cures through a novel approach using circular single-stranded DNA (ssDNA). This innovative biomaterial offers the advantages of both double-stranded DNA stability and RNA flexibility, making it a promising tool for gene editing. Kano's proprietary fermentation-based ssDNA production technique allows for the creation of gene-length circular ssDNA templates, a superior building block for genomic engineering compared to traditional methods.

Kano's platform combines design, manufacturing, and screening to deliver optimized DNA templates for gene editing. These templates aim to break down manufacturing bottlenecks, enable longer DNA insertions, and unlock novel gene editing targets. The company is committed to making gene editing more accessible and affordable, building a databank linking ssDNA sequence design to activity to speed up development timelines. With a focus on environmental stewardship and a passionate team, Kano is actively seeking talent to join their mission of pushing gene editing towards cures.

Kano Therapeutics is a biotech company focused on developing safe and effective genetic payloads for gene-length stretches of DNA through a new class of biomaterial: circular single-stranded DNA. Their mission is to create complete cures for genetic diseases by providing optimized DNA donor material that complements existing gene editing tools, enabling precise insertion of long stretches of DNA and minimizing off-target effects. Kano leverages a fermentation-based DNA production method to make their technology affordable and accessible, while also building a databank to expedite development timelines and reduce costs for their partners.

Kano Therapeutics fosters a culture that is science-driven, innovative, and collaborative. With a strong emphasis on environmental stewardship, the company values its employees' passion for pushing gene editing towards cures. The company's commitment to developing cutting-edge biomaterials and building a platform for single-stranded DNA products reflects a forward-thinking and ambitious mindset. Kano's founder-led team emphasizes a collaborative approach, with open positions available for individuals who are passionate about pushing the boundaries of gene editing.